BertHO'NeilMD

Clinical Trials

• Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2005 Jul 01

  Completed

  Phase 2

• Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer Start of enrollment: 2004 Aug 01

  Completed

  Phase 1

• Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer Start of enrollment: 2003 Apr 01

  Completed

  Phase 1

• Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Start of enrollment: 2003 Dec 01

  Completed

• Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer Start of enrollment: 2006 Oct 01

  Completed

  Phase 2

• Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer Start of enrollment: 2005 Mar 01

  Completed

  Phase 2

• Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab Start of enrollment: 2008 Mar 01

  Terminated

  Phase 2

• Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2007 Nov 01

  Completed

  Phase 2

• Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment Start of enrollment: 2008 Mar 01

  Completed

  Phase 1

• Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis Start of enrollment: 2008 Oct 01

  Terminated

  Phase 1

• Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status Start of enrollment: 2009 May 01

  Completed

  Phase 2

• Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Start of enrollment: 2009 Jul 22

  Completed

  Phase 1

• Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01

  Active, not recruiting

  Phase 3

• E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma Start of enrollment: 2011 Jul 19

  Completed

  Phase 1, Phase 2

• Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer Start of enrollment: 2011 Apr 07

  Completed

  Phase 2

• PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study Start of enrollment: 2012 Oct 01

  Completed

• A Study of BBI503 in Adult Patients With Advanced Solid Tumors Start of enrollment: 2012 Feb 01

  Completed

  Phase 1

• Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy Start of enrollment: 2012 Oct 01

  Completed

• Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib Start of enrollment: 2013 Aug 01

  Completed

  Phase 2

• Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors Start of enrollment: 2013 Jun 01

  Completed

  Phase 1

• MEK162 for Patients With RAS/RAF/MEK Activated Tumors Start of enrollment: 2013 Oct 10

  Completed

  Phase 2

• Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer Start of enrollment: 2013 Dec 01

  Terminated

  Phase 1, Phase 2

• Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer Start of enrollment: 2013 Nov 01

  Completed

  Phase 1

• Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer Start of enrollment: 2014 May 01

  Active, not recruiting

  Phase 2

• BGJ398 for Patients With Tumors With FGFR Genetic Alterations Start of enrollment: 2014 Jul 24

  Terminated

  Phase 2

• LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) Start of enrollment: 2014 Aug 25

  Completed

  Phase 2

• Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the Pancreas Start of enrollment: 2014 Jul 01

  Withdrawn

• A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors Start of enrollment: 2015 Apr 07

  Completed

  Phase 1

• Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors Start of enrollment: 2015 Jul 13

  Terminated

  Phase 1, Phase 2

• MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma Start of enrollment: 2016 Jul 18

  Terminated

  Phase 1, Phase 2

• Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers Start of enrollment: 2016 Jan 01

  Completed

  Phase 1

• A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body Start of enrollment: 2016 Mar 08

  Completed

  Phase 1

• Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma Start of enrollment: 2019 Dec 01

  Not yet recruiting

  Phase 1

  Roles: Principal Investigator, Contact

• Join now to see all